InvestorsHub Logo
icon url

sharonc

05/15/18 9:27 AM

#128119 RE: MontanaState83 #128114

Insurance companies only care about their cost within the current plan year. Amarin needs to get a real indication from the FDA for triglycerides 200-500 before insurance companies will cover these drugs. At that point, they will then need to go back to the individual plans and negotiate price.

Until then, Vascepa will continue to be for those with triglycerides > 500 who also take a statin or for those patients with resources willing to pay out of pocket.
icon url

Biobillionair

05/15/18 11:43 AM

#128129 RE: MontanaState83 #128114

I honestly forget sometimes how stupid the FDA will look by delaying the label even by one day after results are published.---BB